News Daily News Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA Caitlin E. Cox March 21, 2024
News Daily News First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease Michael O'Riordan March 20, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2024 Shelley Wood March 01, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Daily News TAVI Proficiency Doesn’t Spell Success for M-TEER at Large US Sites Michael O'Riordan February 13, 2024
News Daily News FDA Approves First Transcatheter Tricuspid Valve Replacement Device L.A. McKeown February 02, 2024
News Conference News STS 2024 TAVI, SAVR Almost Equally Performed in California Patients Under 60 Yael L. Maxwell February 01, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2024 Shelley Wood February 01, 2024
News Daily News Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest Michael O'Riordan January 30, 2024
News Opinion Off Script My Hopes for Cardiology in 2024: More Honesty, Humility, and Collaboration Benoy Shah, MBBS, MD(Res) January 24, 2024
News Daily News Socioeconomics Mire Access to All AVR Options for Aortic Stenosis Yael L. Maxwell January 22, 2024
News Features Going Solo: Can TAVI Be Performed Without a Surgical Safety Net? Michael O'Riordan January 22, 2024
News Daily News DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants Shelley Wood January 17, 2024
News Daily News Top Policy and Practice News for Cardiologists in 2023 Caitlin E. Cox December 20, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2023 Shelley Wood November 30, 2023
News Conference News PCR London Valves 2023 Acute Decompensated Aortic Stenosis: Time for an Urgent TAVI Pathway? Shelley Wood November 20, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2023 Shelley Wood November 01, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023